Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Glucagon-like peptides 1 and 2 in health and disease: A reviewMarathe, C.; Rayner, C.; Jones, K.; Horowitz, M.
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.
2015Relationships of early and late glycemic responses with gastric emptying during an oral glucose tolerance testMarathe, C.; Horowitz, M.; Trahair, L.; Wishart, J.; Bound, M.; Lange, K.; Rayner, C.; Jones, K.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2013Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetesWu, T.; Bound, M.; Zhao, R.; Standfield, S.; Bellon, M.; Jones, K.; Horowitz, M.; Rayner, C.
2013Mechanisms and clinical efficacy of lixisenatide for the management of type 2 DiabetesHorowitz, M.; Rayner, C.; Jones, K.
2013Prognosis of diabetic gastroparesisa 25-year evaluationChang, J.; Rayner, C.; Jones, K.; Horowitz, M.
2016Small intestinal glucose delivery affects the lowering of blood glucose by acute vildagliptin in type 2 diabetesWu, T.; Zhang, X.; Trahair, L.; Bound, M.; Little, T.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2011Comment on: Chen et al. Utilizing the second-meal effect in Type 2 diabetes: practical use of a soya-yogurt snack. Diabetes Care 2010;33:2552-2554Rayner, C.; Ma, J.; Jones, K.; Horowitz, M.